Clinical Trials on Pars Planitis in New Zealand
Total 186 results
-
Lux Biosciences, Inc.CompletedPanuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, United Kingdom, Canada, Germany, Austria, France, India
-
Lux Biosciences, Inc.CompletedPanuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, United Kingdom, Canada, Germany, Austria, France, India
-
MallinckrodtTerminatedPanuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States
-
EyePoint Pharmaceuticals, Inc.CompletedPanuveitis | Posterior Uveitis | Intermediate UveitisIndia
-
Alumis IncActive, not recruitingUveitis, Intermediate | Noninfectious Panuveitis | Uveitis Posterior Non-InfectiousUnited States
-
Clearside Biomedical, Inc.CompletedUveitis, Anterior | Panuveitis | Uveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, India
-
Clearside Biomedical, Inc.CompletedUveitis, Anterior | Panuveitis | Uveitis | Macular Edema | Uveitis, Posterior | Uveitis, IntermediateUnited States
-
Clearside Biomedical, Inc.CompletedUveitis, Anterior | Panuveitis | Uveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, Israel, India
-
Syneos HealthUS Specialty Formulations, LLCCompletedSARS-CoV-2 (COVID-19)New Zealand
-
Novartis PharmaceuticalsCompletedNon-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious PanuveitisUnited States, United Kingdom
-
Priovant Therapeutics, Inc.Active, not recruitingNon-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious Pan UveitisUnited States
-
NeuroActiva, Inc.Biomed Industries, Inc.UnknownCovid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)New Zealand, United States
-
Valneva Austria GmbHCompletedSARS-CoV-2 InfectionNew Zealand, Netherlands
-
Valneva Austria GmbHCompleted
-
Vaccine Company, Inc.Active, not recruitingSARS-CoV-2 | SARS-CoVUnited States
-
DurectTerminatedSARS-CoV-2United States
-
Chinese University of Hong KongCompletedIntention to Get SARS-CoV-2 Vaccination | Intention to Get SARS-CoV-2 Antibody TestHong Kong
-
Yale UniversityCompletedSARS-CoV-2United States
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingPart 1：r/r B-cell Malignancies | Part 2：B-cell MalignanciesUnited States, Poland, Israel, Ukraine
-
ModernaTX, Inc.Aetion, Inc.Active, not recruiting
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
National Cancer Institute (NCI)RecruitingMetastatic Alveolar Soft Part Sarcoma | Unresectable Alveolar Soft Part SarcomaUnited States
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
Tonix Pharmaceuticals, Inc.Premier Research Group plcActive, not recruitingDetection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2United States
-
PfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
TScan Therapeutics, Inc.CompletedIdentify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection | Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA TypesUnited States
-
LumiraDx UK LimitedSuspendedCOVID-19 | SARS-CoV-2 | Influenza A | Influenza BUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingSarcoma | Undifferentiated Pleomorphic Sarcoma | Alveolar Soft Part Sarcoma | MyxofibrosarcomaUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawnCOVID-19 | COVID19 | Sars-CoV2 | SARS-Cov-2United States
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)CompletedSARS-CoV2 InfectionUnited States
-
NYU Langone HealthRecruitingNeuropsychiatric Post-Acute Sequelae of SARS-CoV-2 InfectionUnited States
-
ModernaTX, Inc.Completed
-
NYU Langone HealthRecruitingCOVID-19 | SARS CoV 2 InfectionUnited States
-
SAb Biotherapeutics, Inc.Department of Health and Human Services; JPEO, Chemical, Biological, Radiological...CompletedCOVID-19 | SARS-CoV2United States
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
Rutgers, The State University of New JerseyUniversity Hospital - Newark, NJNo longer availableCOVID-19 | SARS-CoV 2 | SARS-CoV InfectionUnited States
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaboratorsCompletedSARS-CoV 2United States
-
Infinity Pharmaceuticals, Inc.Active, not recruitingAdvanced Solid Tumors (Part A/B/C/D) | Non-small Cell Lung Cancer (Part E) | Melanoma (Part E) | Squamous Cell Cancer of the Head and Neck (Part E) | Triple Negative Breast Cancer (Part F) | Adrenocortical Carcinoma (Part G) | Mesothelioma (Part G) | High-circulating Myeloid-derived Suppressor Cells...United States
-
ModernaTX, Inc.Completed
-
Rutgers, The State University of New JerseyActive, not recruiting
-
PfizerCompletedCovid-19 | Immunocompromised | Breakthrough Infection | SARS-COV-2 Infection | SARS-COV-2 | ImmunosuppressedUnited States
-
MP Biomedicals, LLCEDP BiotechCompletedCOVID-19 | SARS-CoV2 InfectionUnited States
-
ModernaTX, Inc.Recruiting
-
Swedish Orphan BiovitrumTerminated
-
University of WashingtonBill and Melinda Gates FoundationCompletedCOVID-19 | Corona Virus Infection | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)United States
-
MiCo BioMed Co., Ltd.SyntactxCompletedSARS-CoV2 InfectionUnited States
-
Tulane UniversityNational Institutes of Health (NIH)Active, not recruitingAsthma | Bronchiolitis | Respiratory Syncytial Virus (RSV) | SARS CoV 2 InfectionUnited States